Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. While nothing much came from biotech majors, Amicus FOLD and Editas EDIT were in focus on updates. Recap of ...

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

The relatives of people who died after being given blood infected with HIV and hepatitis can now apply for interim ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

Researchers at the Icahn School of Medicine have unveiled the AMETA Nanobody Platform, which effectively combats SARS-CoV-2 ...

Life challenges make this population very difficult to treat, but interventions that take their issues into account may ...

Researchers assessed whether switching to protease inhibitor-based antiretroviral therapy mitigates or reverses weight gain in patients with HIV infection.

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Today, the international medical humanitarian organisation Médecins Sans Frontières / Doctors Without Borders (MSF), ...